HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

GSK2485852

inhibits hepatitis C virus polymerase; structure in first source

Also Known As:

GSK5852

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Inorganic Chemicals: 9
- Acids: 53217
  - Noncarboxylic Acids
    - Boronic Acids: 200
      - GSK2485852: 1
- Boron Compounds: 91
  - Boronic Acids: 200
    - GSK2485852: 1
Organic Chemicals: 133

Experts

1.	Adkison, Kimberly: 1 article (11/2014)
2.	Baptiste-Brown, Sharon: 1 article (11/2014)
3.	Gan, Jianjun: 1 article (11/2014)
4.	Kim, Joseph: 1 article (11/2014)
5.	Lee, Daniel: 1 article (11/2014)
6.	Lovern, Mark: 1 article (11/2014)
7.	Mathis, Amanda: 1 article (11/2014)
8.	Moss, Lee: 1 article (11/2014)
9.	Shotwell, Brad: 1 article (11/2014)
10.	Spaltenstein, Andrew: 1 article (11/2014)

Related Diseases

1.	Hepatitis C 11/01/2014 - "A randomized, double blind, dose escalation, first time in human study to assess the safety, tolerability, pharmacokinetics, and antiviral activity of single doses of GSK2485852 in chronically infected hepatitis C subjects."

Related Drugs and Biologics

1.	Antiviral Agents (Antivirals)